Stereotaxis Shares to Begin Trading on NYSE American Sept.
Stereotaxis Shares to Begin Trading on NYSE American Sept. 6
5:43 pm ET September 3, 2019 (Dow Jones) Print
By Stephen Nakrosis
Robotic technology company Stereotaxis (STXS) said Tuesday its common stock has been approved for listing on the NYSE American exchange.
The company's shares will begin trading on the exchange on Sept. 6 under the symbol "STXS."
Currently, the company's shares trade over-the-counter. They closed Tuesday's regular trading session with a gain of 5.06%, to finish at $2.70.
Stereotaxis has 59.3 million shares outstanding and a public float of 44.34 million shares. The company has a market cap of $152.72 million.
Stereotaxis develops robotic technology used to treat cardiac arrhythmias, it said.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
September 03, 2019 17:43 ET (21:43 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.
Market data and information provided by Morningstar.
Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Information and news provided by ,, , Computrade Systems, Inc., , and
Copyright © 2019. All rights reserved.
CFRA Research Disclosure
3rd Party Research Disclosure
Stereotaxis (STXS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...
Continue Reading
Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...
Continue Reading
Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...
Continue Reading
Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....
Continue Reading
The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...
Continue Reading
Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...
Continue Reading
Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...
Continue Reading
Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...
Continue Reading
Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of the Easterly ROCMuni High Income Fund Lawsuit Investors in the Easterly ROCMuni High Income Municipal Bond Fund are being urged to consider their rights as part of a potential class action lawsuit. This fund was previously known as the Principal Street High Income Municipal Fund and is associated with the James Alpha Funds Trust. Investors who purchased shares...
Continue Reading
BioPhorum Forms Strategic Advisory Board for Enhanced Collaboration BioPhorum, a trusted name in the pharmaceutical industry, has taken a significant step towards fostering collaboration within the sector. The formation of its inaugural Strategic Advisory Board aims to provide pivotal guidance and insights, driving the overall direction of the organization as it tackles...
Continue Reading
Maxeon Solar Solutions Tapped for Major Solar Projects At a recent clean energy gathering, Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN)—long known for pushing solar technology forward—announced a new collaboration with Cypress Creek Renewables. Together, the companies will deploy Maxeon solar panels across key power plant projects nationwide, expanding reliable...
Continue Reading
Transforming Healthcare Through Reliable Partnerships In healthcare environments worldwide, a vital force is improving lives—VARON Oxygen Solutions. This company has emerged as a trusted provider of oxygen concentrators, ensuring that patients receive high-quality respiratory care wherever they are, including hospitals and senior living facilities. Bridging Global Gaps...
Continue Reading
Intelligent Blends Enhances Its Market Position New Non-GMO Certification and Enhanced Capabilities Position Company for Expanded Growth in Functional Beverages Intelligent Blends has officially solidified its place as a leader in the "better for you" manufacturing sector, having recently obtained Non-GMO certification. This achievement reflects the company’s commitment...
Continue Reading